LIVZON PHARMA(01513) reported a net profit attributable to shareholders of RMB 1.288 billion for the first three quarters, down 26.57% year on year.
LIVZON PHARMA (01513) announced that for the first three quarters of 2026, operating revenue was RMB 7.319 billion, down 19.71% year on year; net profit attributable to shareholders of the listed company was RMB 1.288 billion, down 26.57% year on year; basic earnings per share were RMB 1.45.
LIVZON PHARMA(01513) announced that for the first three quarters of 2026, operating revenue was RMB 7.319 billion, down 19.71% year on year; net profit attributable to shareholders of the listed company was RMB 1.288 billion, down 26.57% year on year; basic earnings per share were RMB 1.45.
Related Articles
UBOX ONLINE (02429) repurchased 16,000 shares on October 23 for HK$22,300.
DAWNRAYS PHARMA (02348) repurchased 236,000 shares on October 23 for HK$223,200.
MNSO (09896) repurchased 100,000 shares on October 23 for HK$1.9918 million.
UBOX ONLINE (02429) repurchased 16,000 shares on October 23 for HK$22,300.
DAWNRAYS PHARMA (02348) repurchased 236,000 shares on October 23 for HK$223,200.
MNSO (09896) repurchased 100,000 shares on October 23 for HK$1.9918 million.
